Human Biobanking market is expected to reach US$37.1 billion 2020 primarily supported by application; Stem Cells, Blood and Blood Products, Research and Pharmaceuticals…etc. Among the Human Biobanking Application market, Advance Application is the fastest growing market with a CAGR of 9.65%. Organs and Research application in human banking together accounts approximately for 24% of the market share. Stem Cells, Blood and Blood Products, Research market with a positive growth rate during the period. Human Biobanking Industry is playing an increasing role in development of therapies and diagnosis of diseases with well-maintained researchers and institutions.

1. www.axisresearchmind.com | Copyright © 2016 | All Rights Reserved
HUMAN BIOBANKING APPLICATIONS -
GLOBAL TRENDS, ESTIMATES AND
FORECASTS, 2014-2020
PRICE: US$4800
NO. OF PAGES: 596
TABLES/CHARTS: 157
REPORT CODE: ARMMR163N
PUBLICATION: MAY 2016

2. www.axisresearchmind.com | Copyright © 2016 | All Rights Reserved
For more information on this report publication, please reach us at:
sales@axisresearchmind.com 2
HUMAN BIOBANKING APPLICATIONS - GLOBAL TRENDS, ESTIMATES
AND FORECASTS, 2014-2020
SEGMENTATION
Human Biobanking Applications
The analysis primarily deals with human biobanking applications market. Further, the
subdivided categories include:
 STEM CELLS
 BLOOD1
& BLOOD PRODUCTS
 ORGANS2
 ADVANCED APPLICATIONS
o BIOMARKERS
o GENOMICS3
o DRUG DISCOVERY
o FORENSICS
 RESEARCH
 PHARMACEUTICALS
 OTHER4
1. Red Blood Cells, Plasma and Platelets
2. Tissue Sections, Liver, Eyes, Kidney, Brain, Heart and Other
3. DNA, RNA, Protein Extraction, Molecular Derivatives, Cell Cultures, Microarrays, Cytogenetics, etc.
4. Body Fluids (Synovial, Urine, Sputum, Buccal Scrapings and Sperm), Contract Services and Process Chemicals
HUMAN BIOBANKING APPLICATIONS
- GLOBAL MARKET WATCH, 2014-2020
Human Biobanking market is expected to reach US$37.1 billion 2020 primarily supported
by application; Stem Cells, Blood and Blood Products, Research and
Pharmaceuticals…etc. Among the Human Biobanking Application market, Advance
Application is the fastest growing market with a CAGR of 9.65%. Organs and Research
application in human banking together accounts approximately for 24% of the market
share. Stem Cells, Blood and Blood Products, Research market with a positive growth
rate during the period. Human Biobanking Industry is playing an increasing role in
development of therapies and diagnosis of diseases with well-maintained researchers
and institutions.
Getting the most from our custom research
Knowing Future by Analyzing the Market in Key Growth Areas and New Technologies…!!!

3. www.axisresearchmind.com | Copyright © 2016 | All Rights Reserved
For more information on this report publication, please reach us at:
sales@axisresearchmind.com 3
HUMAN BIOBANKING APPLICATIONS - GLOBAL TRENDS, ESTIMATES
AND FORECASTS, 2014-2020
KEY COMPANIES PROFILED
VERICEL CORPORATION, ACORDA THERAPEUTICS, INC., ALPHA CORD, INC.,
AFFYMETRIX, INC., CELLERANT THERAPEUTICS, INC., CRYO-CELL INTERNATIONAL, INC.,
MESOBLAST, INC., BECKMAN COULTER, INC., BIOSTORAGE, LLC., CHART INDUSTRIES,
INC., CHARTER MEDICAL, LTD., CORD BLOOD REGISTRY, CRYOLIFE, INC.,
CRYOMAGNETICS, INC., CRYOPLUS, INC., CRYOXTRACT, HAMILTON STORAGE
TECHNOLOGIES, LABVANTAGE SOLUTIONS, INC., LABWARE, INC., LIFENET HEALTH,
QIAGEN NV, RAND CORPORATION, ABBOTT
LABORATORIES, STEM CELLS, INC., STEMCELL
TECHNOLOGIES, INC., LIFELINE® CELL
TECHNOLOGY, THERMO FISHER SCIENTIFIC,
INC., WHEATON SCIENCE PRODUCTS, INC.,
PANASONIC BIOMEDICAL B.V, EPISTEM LTD., BBMRI, BIOBANK IRELAND TRUST, BIOKRYO
GMBH, BIOREP SRL P.IVA, BIOSTORAGE TECHNOLOGIES, INC., CRYO BIO SYSTEM, CRYO-
SAVE, AG, GE HEALTHCARE LIFE SCIENCES, SANOFI AVENTIS, SOVENTEC GMBH, TECAN,
UK STEM CELL BANK, CORDLIFE PTE., LTD., CRYOCORD SDN. BHD., CRYOLOGIC PTY.
LTD., GENESEARCH, OCIMUM BIOSOLUTIONS, RELIANCE LIFE SCIENCES, CHINA CORD
BLOOD CORPORATION, BABYCELL EGYPT, GAMIDA CELL LTD., & many more….
REPORT FOCUS
The report “Human Biobanking Applications - Global Trends, Estimates and Forecasts,
2014-2020” reviews the latest human biobanking market trends with a perceptive
attempt to disclose the near-future growth prospects. An in-depth analysis on a
geographic basis provides strategic business intelligence for life science sector
investments. The study reveals profitable investment strategies for pharmaceutical
manufacturers, biotechnology companies, laboratories, Contract Research Organizations
(CROs) and many more in preferred locations.
The report focuses on the current market trends, estimates and forecasts for the
period 2014-2020. More than 1250 leading market players are identified and 107 key
companies that project improved market activities in the near future are profiled. The
report consists of 157 data charts describing the market shares, sales forecasts and
growth prospects. Moreover, key strategic activities in the market including
mergers/acquisitions, collaborations/partnerships, product launches/developments
are discussed.
“Learn High Potential Market Dynamics
for Strategic Business Planning”

4. www.axisresearchmind.com | Copyright © 2016 | All Rights Reserved
For more information on this report publication, please reach us at:
sales@axisresearchmind.com 4
HUMAN BIOBANKING APPLICATIONS - GLOBAL TRENDS, ESTIMATES
AND FORECASTS, 2014-2020
GEOGRAPHIC COVERAGE
Estimates are based on online surveys using customized questionnaires by our research
team. Besides information from government databases, company websites, press
releases & published research reports are also used for estimates.
The market growth rate in the major economies such as the U.S., Japan, China etc.
are estimated individually.
The region wise distribution of the market consists of North America, Europe, Asia-Pacific,
and Rest of World with 18 countries, analyzed individually as follows:
NORTH AMERICA USA, CANADA AND MEXICO
EUROPE
UNITED KINGDOM, GERMANY, FRANCE, SPAIN, ITALY, THE
NETHERLANDS, SWITZERLAND, RUSSIA AND REST OF EUROPE
ASIA-PACIFIC CHINA, JAPAN, INDIA, SOUTH KOREA AND REST OF ASIA-PACIFIC
REST OF THE WORLD
BRAZIL, MIDDLE EAST, SOUTH AFRICA, REST OF LATIN AMERICA
AND REST OF AFRICA
KEY INDUSTRY ACTIVITIES
 CESCA THERAPEUTICS ENTERS INTO COLLABORATIVE AGREEMENT WITH CENTER FOR
IMMUNE CELL THERAPIES AT MEMORIAL SLOAN KETTERING CANCER CENTER
 AGILENT TECHNOLOGIES TO ACQUIRE SEAHORSE BIOSCIENCE, INDUSTRY LEADER IN
TOOLS FOR MEASURING CELL METABOLISM
 INTERNATIONAL STEM CELL CORPORATION ANNOUNCES NEXT PHASE OF RESEARCH
COLLABORATION WITH ROHTO PHARMACEUTICAL CO., LTD. OF JAPAN
 PARTNERS GET $12.3M TO ADVANCE GENOMIC MEDICINE
 NEW STUDY DEMONSTRATES ABSENCE OF EXTRACTABLE ORGANIC CONTAMINANTS IN
MICRONIC’S POLYPROPYLENE SAMPLE STORAGE TUBES
 VALEANT PHARMACEUTICALS TO ACQUIRE SYNERGETICS USA
 SYSMEX RECEIVES IN-VITRO DIAGNOSTIC APPROVAL FOR MANUFACTURING AND
SALES OF THREE PLATELET AGGREGATION AGONIST REAGENT KITS
 AMAG PHARMACEUTICALS COMPLETES ACQUISITION OF CORD BLOOD REGISTRY
 BIOTEK SYNERGY™ NEO2 GRANTED CISBIO HTRF® CERTIFICATION
 AVITA MEDICAL ANNOUNCES NEW RESEARCH PARTNERSHIP WITH UNIVERSITY OF
HUDDERSFIELD
& many more….